Call Options

29 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$460.0 - $505.78 $8.33 Million - $9.15 Million
18,100 Added 6.16%
312,000 $145 Million
Q2 2024

Aug 15, 2024

BUY
$392.81 - $485.53 $15.3 Million - $18.9 Million
38,900 Added 15.25%
293,900 $138 Million
Q1 2024

May 07, 2024

SELL
$407.69 - $446.08 $112 Million - $122 Million
-274,500 Reduced 51.84%
255,000 $107 Million
Q4 2023

Feb 14, 2024

BUY
$343.0 - $410.68 $8.61 Million - $10.3 Million
25,100 Added 4.98%
529,500 $215 Million
Q3 2023

Nov 14, 2023

BUY
$338.18 - $362.46 $66.7 Million - $71.4 Million
197,100 Added 64.14%
504,400 $175 Million
Q2 2023

Aug 11, 2023

BUY
$314.42 - $351.91 $9.15 Million - $10.2 Million
29,100 Added 10.46%
307,300 $108 Million
Q1 2023

May 16, 2023

SELL
$283.23 - $323.1 $12.6 Million - $14.4 Million
-44,500 Reduced 13.79%
278,200 $87.7 Million
Q4 2022

Feb 14, 2023

SELL
$285.76 - $321.48 $29.1 Million - $32.8 Million
-101,900 Reduced 24.0%
322,700 $93.2 Million
Q3 2022

Nov 14, 2022

BUY
$273.83 - $305.53 $16.1 Million - $17.9 Million
58,700 Added 16.04%
424,600 $123 Million
Q2 2022

Aug 15, 2022

SELL
$234.96 - $292.55 $33.8 Million - $42.1 Million
-144,000 Reduced 28.24%
365,900 $103 Million
Q1 2022

May 16, 2022

SELL
$221.42 - $260.97 $8.72 Million - $10.3 Million
-39,400 Reduced 7.17%
509,900 $133 Million
Q4 2021

Feb 14, 2022

SELL
$177.01 - $223.45 $9.1 Million - $11.5 Million
-51,400 Reduced 8.56%
549,300 $121 Million
Q3 2021

Nov 15, 2021

SELL
$181.39 - $202.99 $47.5 Million - $53.1 Million
-261,800 Reduced 30.35%
600,700 $109 Million
Q2 2021

Aug 11, 2021

BUY
$187.49 - $221.1 $74.1 Million - $87.3 Million
395,000 Added 84.49%
862,500 $174 Million
Q1 2021

May 17, 2021

BUY
$207.02 - $241.31 $58.2 Million - $67.8 Million
281,100 Added 150.8%
467,500 $100 Million
Q4 2020

Feb 16, 2021

BUY
$207.01 - $276.09 $621,030 - $828,269
3,000 Added 1.64%
186,400 $44.1 Million
Q3 2020

Nov 16, 2020

SELL
$255.65 - $303.1 $9.15 Million - $10.9 Million
-35,800 Reduced 16.33%
183,400 $49.9 Million
Q2 2020

Aug 14, 2020

SELL
$225.48 - $295.8 $25 Million - $32.8 Million
-110,900 Reduced 33.6%
219,200 $63.6 Million
Q1 2020

May 15, 2020

BUY
$199.77 - $247.81 $43.7 Million - $54.2 Million
218,600 Added 196.05%
330,100 $78.5 Million
Q4 2019

Feb 14, 2020

SELL
$166.71 - $223.91 $33.4 Million - $44.8 Million
-200,200 Reduced 64.23%
111,500 $24.4 Million
Q3 2019

Nov 14, 2019

BUY
$166.23 - $187.09 $6.75 Million - $7.6 Million
40,600 Added 14.98%
311,700 $52.8 Million
Q2 2019

Aug 14, 2019

BUY
$164.61 - $190.37 $7.51 Million - $8.68 Million
45,600 Added 20.22%
271,100 $49.7 Million
Q1 2019

May 15, 2019

SELL
$163.73 - $194.7 $98.5 Million - $117 Million
-601,700 Reduced 72.74%
225,500 $41.5 Million
Q4 2018

Feb 14, 2019

BUY
$151.91 - $192.21 $50.1 Million - $63.4 Million
330,100 Added 66.41%
827,200 $137 Million
Q3 2018

Nov 14, 2018

BUY
$167.73 - $192.74 $13.1 Million - $15.1 Million
78,300 Added 18.7%
497,100 $95.8 Million
Q2 2018

Aug 14, 2018

BUY
$145.72 - $169.96 $16.8 Million - $19.6 Million
115,600 Added 38.13%
418,800 $71.2 Million
Q1 2018

May 15, 2018

BUY
$151.6 - $177.13 $742,840 - $867,937
4,900 Added 1.64%
303,200 $49.4 Million
Q4 2017

Feb 14, 2018

SELL
$137.28 - $155.55 $76.6 Million - $86.8 Million
-558,300 Reduced 65.18%
298,300 $44.7 Million
Q3 2017

Nov 14, 2017

BUY
$148.13 - $162.24 $127 Million - $139 Million
856,600
856,600 $130 Million

Others Institutions Holding VRTX

About VERTEX PHARMACEUTICALS INC


  • Ticker VRTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 256,691,008
  • Market Cap $105B
  • Description
  • Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...
More about VRTX
Track This Portfolio

Track Susquehanna International Group, LLP Portfolio

Follow Susquehanna International Group, LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna International Group, LLP with notifications on news.